Rickets Market is Expected to Grow at a CAGR over 5.90% from 2022 to 2030

Pune, India, November, 2021 /MRFR Press Release/- Market Research Future published a half-cooked research report on global rickets market. 

Market Highlights

Rickets is a disorder caused by lack of vitamin D, and minerals such as calcium, or phosphate. It leads to softening and weakening of the bones. Vitamin D helps the body control calcium and phosphate levels. If the blood levels of these minerals become too low, the body may produce hormones that cause calcium and phosphate to be released from the bones. This leads to weak and soft bones. According to National Health and Nutrition Examination Survey, in 2013, 45 % people in the U.S. are suffering from vitamin D deficiency. Increasing patient population, and changing lifestyle has driven the growth of the market. Moreover, poor lifestyle and increasing geriatric population has fuelled the growth of the market. On the other hand, high cost of the treatment may slow the market growth.

Rickets Market is expected to reach USD 1,503.50 Million by 2030 at 5.90% CAGR during the forecast period 2022-2030.

Segmentation

The global rickets market is segmented on the basis of types, causes, therapy, and end users.

On the basis of types, the market is segmented vitamin D-related rickets, hypocalcemia-related rickets, hypophosphatemia-related rickets, and others. Vitamin D-related rickets is further segmented into vitamin D deficiency, and vitamin D-dependent rickets. Hypophosphatemia-related rickets is further segmented into congenital, hypophosphatemia, fanconi's syndrome, and others.

On the basis of causes, the market is categorised into sunlight, diet, genetics and others

On the basis of therapy, the market is segmented into diagnosis and treatment. Diagnosis is further segmented into blood tests, bone density scan, radiography, and others. Treatment is subsegmented into diet & sunlight therapy, supplementation, and others.

On the basis of end users, the market is segmented into hospital, clinics, and others. 

Regional Analysis

The Americas dominate the global rickets market owing to a large patient population, strong government support for research & development, and high healthcare spending. According to National Health and Nutrition Examination Survey, the number of patients in the U.S. suffering from vitamin D deficiency is increasing continuously. Additionally, changing lifestyle and poor diet has fuelled the growth of the market. 

Europe has the second leading market in global rickets market which is followed by Asia Pacific. Asia Pacific is the fastest growing market for Rickets. As per statistics, the U.K and Germany has a huge number of patients suffering from vitamin D deficiency. Asia Pacific rickets market is majorly driven by Indian and China owing to a huge patient pool, and continuously developing healthcare sector have fuelled the growth of the market.

The Middle East and Africa contribute the least in the growth of global rickets market. The Middle East dominates the market for The Middle East and Africa. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East market. Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition. However the growth of the Africa market is high due to the presence of opportunities for the development of the market.

Key Players

The key players for the global rickets market are Koninklijke DSM N.V. (the Netherlands), Nestlé S.A. (Switzerland), ADM Alliance Nutrition, Inc. (U.S.), Groupe Danone S.A. (France), Abbott (U.S.), and Kraft Foods Group, Inc. (U.S.), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pfizer (U.S.), and Sun Pharmaceutical Industries Ltd (India)

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of  Rickets Market Research Report